Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed.
Hickey MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, Imbert E, Spinelli M, Szumowski JD, Appa A, Koester K, Dauria EF, McNulty M, Colasanti J, Havlir DV, Gandhi M, Christopoulos KA.
Hickey MD, et al.
J Acquir Immune Defic Syndr. 2024 Mar 27. doi: 10.1097/QAI.0000000000003421. Online ahead of print.
J Acquir Immune Defic Syndr. 2024.
PMID: 38534179